Biogen Idec Inc. (NASDAQ: BIIB) posted better-than-expected fourth quarter results on Tuesday, while also guiding for current year earnings ahead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE